\-\ Texto\\:\\ \ \(0\)\
\-\ eye\\ examination\\ and\\ confrontational\\ testing\\ revealed\\ a\\ bitemporal\\ hemianopia\\ with\\ an\\ additional\\ superonasal\\ defect\\ in\\ the\\ right\\ eye\\.\\ od\\ 20\\/200\\,\\ os\\ 20\\/20\\.\ \(0\)\
\-\ large\\ mass\\ on\\ t1\\ isointense\\ to\\ gray\\ matter\\ arising\\ from\\ the\\ sella\\ with\\ mass\\ effect\\ on\\ the\\ optic\\ chiasm\\.\\ post\\ contrast\\ shows\\ heterogeneous\\ enhancement\\.\\ no\\ visible\\ pituitary\\ gland\\ seen\\.\ \(0\)\
\-\ pituitary\\ macroadenoma\ \(8\)\
\-\ differential\\ diagnosis\\:\\ craniopharyngioma\\,\\ meningioma\\,\\ glioma\\,\\ germ\\ cell\\ tumor\\,\\ metastatic\\ disease\ \(0\)\
\-\ 36\\ year\\ old\\ latin\\ american\\ male\\ presents\\ with\\ headaches\\ and\\ visual\\ disturbances\\.\ \(1\)\
\-\ \\>10mm\\ in\\ size\ \(1\)\
\-\ less\\ common\\ than\\ pituitary\\ microadenomas\ \(0\)\
\-\ usually\\ non\\-functioning\ \(0\)\
\-\ ages\\ 25\\-60\ \(0\)\
\-\ often\\ symptomatic\\ due\\ to\\ mass\\ effect\\ on\\ surrounding\\ structures\\ \\(optic\\ chiasm\\,\\ cavernus\\ sinus\\,\\ 3rd\\ ventricle\\)\ \(0\)\
\-\ mr\\ imaging\\ characteristics\\:\\ \\ usually\\ isointense\\ to\\ gray\\ matter\\ on\\ all\\ sequences\\,\\ heterogeneous\\ enhancement\\ post\\-gad\\,\\ can\\ contain\\ central\\ areas\\ of\\ necrosis\\.\ \(0\)\
\-\ involvement\\ of\\ the\\ cavernus\\ sinus\\ can\\ be\\ difficult\\ to\\ discern\\.\ \(0\)\
\-\ although\\ pituitary\\ carcinoma\\ is\\ rare\\ \\(\\<1\\%\\ of\\ adenomas\\)\\,\\ it\\ cannot\\ be\\ distinguished\\ by\\ imaging\\ alone\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ cavernus\\:\\ 0\\.10074878198818855\ \(0\)\
\-\ pituitary\\:\\ 0\\.09789528984715982\ \(0\)\
\-\ chiasm\\:\\ 0\\.058032557779235765\ \(0\)\
\-\ superonasal\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ 20\\/200\\:\\ 0\\.05037439099409428\ \(0\)\
\-\ isointense\\:\\ 0\\.04800454751000273\ \(0\)\
\-\ gray\\:\\ 0\\.04778045069413557\ \(0\)\
\-\ confrontational\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ 25\\-60\\:\\ 0\\.04641354996232316\ \(0\)\
\-\ optic\\:\\ 0\\.045208068795483725\ \(0\)\
\-\ hemianopia\\:\\ 0\\.04409660648741936\ \(0\)\
\-\ latin\\:\\ 0\\.042452708930552044\ \(0\)\
\-\ microadenomas\\:\\ 0\\.042452708930552044\ \(0\)\
\-\ non\\-functioning\\:\\ 0\\.041177602923042275\ \(0\)\
\-\ eye\\:\\ 0\\.040964683509850414\ \(0\)\
\-\ discern\\:\\ 0\\.038491867898780924\ \(0\)\
\-\ matter\\:\\ 0\\.038451199661723404\ \(0\)\
\-\ 20\\/20\\:\\ 0\\.0366721322923893\ \(0\)\
\-\ post\\-gad\\:\\ 0\\.03617492442387713\ \(0\)\
\-\ heterogeneous\\:\\ 0\\.03591080179194292\ \(0\)\
\-\ sinus\\:\\ 0\\.03571610251019929\ \(0\)\
\-\ 10mm\\:\\ 0\\.0352940633962928\ \(0\)\
\-\ effect\\:\\ 0\\.03457780860650565\ \(0\)\
\-\ bitemporal\\:\\ 0\\.03453102686700981\ \(0\)\
\-\ od\\:\\ 0\\.03385798094897333\ \(0\)\
\-\ can\\:\\ 0\\.03322666889946976\ \(0\)\
\-\ distinguished\\:\\ 0\\.032977119921389\ \(0\)\
\-\ adenomas\\:\\ 0\\.032457281188784846\ \(0\)\
\-\ macroadenoma\\:\\ 0\\.03221408339210601\ \(0\)\
\-\ disturbances\\:\\ 0\\.03198081485199027\ \(0\)\
\-\ usually\\:\\ 0\\.029656322901334388\ \(0\)\
\-\ os\\:\\ 0\\.029153979184355375\ \(0\)\
\-\ sella\\:\\ 0\\.02813541786203355\ \(0\)\
\-\ ages\\:\\ 0\\.027687008630939296\ \(0\)\
\-\ contain\\:\\ 0\\.02697813635282513\ \(0\)\
\-\ alone\\:\\ 0\\.02643350675394327\ \(0\)\
\-\ enhancement\\:\\ 0\\.026177014469977555\ \(0\)\
\-\ craniopharyngioma\\:\\ 0\\.025857479901817755\ \(0\)\
\-\ germ\\:\\ 0\\.025263252967394623\ \(0\)\
\-\ 36\\:\\ 0\\.024473822461789956\ \(0\)\
\-\ characteristics\\:\\ 0\\.024292401328563785\ \(0\)\
\-\ 3rd\\:\\ 0\\.024174576830262435\ \(0\)\
\-\ testing\\:\\ 0\\.023619355410527305\ \(0\)\
\-\ american\\:\\ 0\\.023260493117732848\ \(0\)\
\-\ visible\\:\\ 0\\.023113335997147617\ \(0\)\
\-\ imaging\\:\\ 0\\.02288084370806403\ \(0\)\
\-\ visual\\:\\ 0\\.02213643429346968\ \(0\)\
\-\ glioma\\:\\ 0\\.02201527882118052\ \(0\)\
\-\ difficult\\:\\ 0\\.021373397764186692\ \(0\)\
\-\ gland\\:\\ 0\\.02079639252224382\ \(0\)\
\-\ sequences\\:\\ 0\\.020391396296034356\ \(0\)\
\-\ mass\\:\\ 0\\.02037361726195825\ \(0\)\
\-\ arising\\:\\ 0\\.02021373579849132\ \(0\)\
\-\ additional\\:\\ 0\\.019579695395142843\ \(0\)\
\-\ symptomatic\\:\\ 0\\.019399905283966925\ \(0\)\
\-\ necrosis\\:\\ 0\\.019274861219684025\ \(0\)\
\-\ rare\\:\\ 0\\.018962001135275977\ \(0\)\
\-\ \\<\\:\\ 0\\.01884608872858166\ \(0\)\
\-\ structures\\:\\ 0\\.01880037419905551\ \(0\)\
\-\ meningioma\\:\\ 0\\.018777653351171857\ \(0\)\
\-\ headaches\\:\\ 0\\.01866538479469302\ \(0\)\
\-\ ventricle\\:\\ 0\\.0182993732433053\ \(0\)\
\-\ defect\\:\\ 0\\.018278556150285296\ \(0\)\
\-\ involvement\\:\\ 0\\.017896792323587523\ \(0\)\
\-\ on\\:\\ 0\\.016546080282638355\ \(0\)\
\-\ less\\:\\ 0\\.01653680002470104\ \(0\)\
\-\ although\\:\\ 0\\.016491024460437737\ \(0\)\
\-\ areas\\:\\ 0\\.01643055526426324\ \(0\)\
\-\ size\\:\\ 0\\.016370719265021552\ \(0\)\
\-\ \\>\\:\\ 0\\.016223814369534652\ \(0\)\
\-\ central\\:\\ 0\\.016066464896342624\ \(0\)\
\-\ surrounding\\:\\ 0\\.01605237293922723\ \(0\)\
\-\ revealed\\:\\ 0\\.01567127937066339\ \(0\)\
\-\ often\\:\\ 0\\.015579848848683728\ \(0\)\
\-\ mr\\:\\ 0\\.015515425553979624\ \(0\)\
\-\ differential\\:\\ 0\\.015502627596302455\ \(0\)\
\-\ t1\\:\\ 0\\.015477117349852822\ \(0\)\
\-\ \\,\\:\\ 0\\.01546914660098785\ \(0\)\
\-\ post\\:\\ 0\\.015376200188984536\ \(0\)\
\-\ examination\\:\\ 0\\.015179560202711802\ \(0\)\
\-\ be\\:\\ 0\\.015060076838216334\ \(0\)\
\-\ carcinoma\\:\\ 0\\.013839586685804952\ \(0\)\
\-\ all\\:\\ 0\\.013810991368178805\ \(0\)\
\-\ shows\\:\\ 0\\.013424992569879307\ \(0\)\
\-\ cell\\:\\ 0\\.013189946923322779\ \(0\)\
\-\ due\\:\\ 0\\.013030155159730512\ \(0\)\
\-\ \\:\\:\\ 0\\.012917426468464744\ \(0\)\
\-\ than\\:\\ 0\\.01279456488524728\ \(0\)\
\-\ common\\:\\ 0\\.012778669782607983\ \(0\)\
\-\ metastatic\\:\\ 0\\.012292053734949087\ \(0\)\
\-\ 1\\:\\ 0\\.011619007816912611\ \(0\)\
\-\ \\%\\:\\ 0\\.01139040590483433\ \(0\)\
\-\ tumor\\:\\ 0\\.011384184580633207\ \(0\)\
\-\ diagnosis\\:\\ 0\\.011212681890173827\ \(0\)\
\-\ it\\:\\ 0\\.01097627648304581\ \(0\)\
\-\ contrast\\:\\ 0\\.01093014678175946\ \(0\)\
\-\ large\\:\\ 0\\.010677385324749027\ \(0\)\
\-\ presents\\:\\ 0\\.009975110260045291\ \(0\)\
\-\ to\\:\\ 0\\.009761556764411115\ \(0\)\
\-\ seen\\:\\ 0\\.009649300657529659\ \(0\)\
\-\ male\\:\\ 0\\.008829745930785561\ \(0\)\
\-\ \\(\\:\\ 0\\.008255562585644121\ \(0\)\
\-\ \\)\\:\\ 0\\.008154716481294915\ \(0\)\
\-\ by\\:\\ 0\\.008130690875684998\ \(0\)\
\-\ disease\\:\\ 0\\.007981357378375452\ \(0\)\
\-\ from\\:\\ 0\\.0072367755037383566\ \(0\)\
\-\ not\\:\\ 0\\.007056106695668202\ \(0\)\
\-\ an\\:\\ 0\\.006752370653055599\ \(0\)\
\-\ year\\:\\ 0\\.005463458681559513\ \(0\)\
\-\ right\\:\\ 0\\.005152181194916667\ \(0\)\
\-\ old\\:\\ 0\\.004999626267784312\ \(0\)\
\-\ no\\:\\ 0\\.00491682371830744\ \(0\)\
\-\ in\\:\\ 0\\.004815968344460056\ \(0\)\
\-\ is\\:\\ 0\\.0032130901621984322\ \(0\)\
\-\ the\\:\\ 0\\.0031599836503685896\ \(0\)\
\-\ a\\:\\ 0\\.0022662845818205786\ \(0\)\
\-\ and\\:\\ 0\\.0020572457797967823\ \(0\)\
\-\ with\\:\\ 0\\.002005785875826681\ \(0\)\
\-\ of\\:\\ 0\\.001997208013679802\ \(0\)\
\-\ \\.\\:\\ 0\\.0016228359358786868\ \(0\)\
